The Readout Loud

283: A CRISPR milestone, algorithms amok, & biotech mixology

11 snips
Nov 16, 2023
Guest
Michael Gilman
Guest
Casey Ross
Investigative reporter Casey Ross reveals how UnitedHealth Group used an algorithm to deny patient care for profit. Biotech veteran Michael Gilman talks about being a startup CEO in the economic downturn and shares cocktail recipes. They also discuss the approval of a groundbreaking CRISPR-based medicine.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

CRISPR-Based Medicine Approved

  • Casgevy is the first CRISPR-based medicine approved, marking a major step for sickle cell treatment.
  • The UK approved it for both sickle cell disease and beta thalassemia, another blood disorder.
INSIGHT

Casgevy's UK Launch and Pricing

  • Casgevy's UK rollout involves negotiations with NICE for reimbursement and patient access.
  • Pricing isn't disclosed yet, and the UK patient population is relatively small.
ANECDOTE

UnitedHealth's Algorithm and Case Management

  • UnitedHealth's algorithm uses patient data to predict rehab stay length, influencing payment decisions.
  • Case managers face pressure to adhere to the algorithm's predictions with little discretion.
Get the Snipd Podcast app to discover more snips from this episode
Get the app